Sorg Elaine K.'s Form 4 filing
AbbVie Inc. (ABBV) · filed Dec 14, 2021
- Accession no.
- 0001179110-21-010958
- Filed
- Dec 14, 2021
- Trade date
- Dec 10-13, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $812.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sorg Elaine K.CIK 0001832571 | Officer (SVP, US Commercial Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | Common Stock, $0.01 par value | FTax withholdingDisposed | −5,137 | $124.15 | −$637,758.55 | 6,458 | Direct | |
| Dec 13, 2021 | Common Stock, $0.01 par value | SSaleDisposed | −3,229 | $125.85 | −$406,369.65 | 3,229 | Direct | |
| Dec 13, 2021 | Common Stock, $0.01 par value | SSaleDisposed | −3,229 | $125.85 | −$406,369.65 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The sale transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).